Humana Inc vs Rigetti Computing Inc — how do they compare? Humana Inc trades at $442.03 (market cap $46.49B), while Rigetti Computing Inc trades at $14.4 (market cap $4.72B). The key difference: Humana Inc is far larger — about 9.8× Rigetti Computing Inc's market cap, and Humana Inc pays a 0.91% dividend while Rigetti Computing Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Humana Inc for 53 Days and Rigetti Computing Inc for 34 Days on average.
| HUM | RGTI | |
|---|---|---|
Market Cap | $46.49B | $4.72B |
Volume | 2,567,704 | 17,136,381 |
Sector | Health | Technology |
52-Week High | $409.85 | $56.34 |
52-Week Low | $163.67 | $12.90 |
Typical Hold Time | 53 Days | 34 Days |
Enterprise Value | $53.84B | $4.33B |
Dividend Yield | 0.91% | — |
Signals from Pluang's Aura AI — not financial advice
Humana (HUM) trades at $396.51, down 1.92% on the day, with strong technical momentum showing bullish moving averages and key support at $391. The company demonstrates consistent revenue growth reaching $129.7B in 2025, though net margins have compressed to 0.88%. Recent quarterly earnings have exceeded expectations, with Q2 2026 EPS of $7.61 beating estimates of $7.27. Analyst sentiment remains positive with a $432.63 consensus price target representing 9% upside potential from current levels.
The investment case centers on Humana's dominant Medicare Advantage position and consistent revenue growth, though margin pressure and regulatory scrutiny present headwinds. With 43% of analysts maintaining buy ratings and institutional accumulation continuing, the stock offers exposure to healthcare demographics but requires monitoring of enrollment trends and cost management execution.
RGTI trades at $14.59, down 3.82% amid bearish technical signals despite bullish analyst sentiment. The quantum computing firm shows minimal revenue growth ($7M in 2025, $13M in 2026) with deep losses (-$216M net income in 2025) and negative margins. Recent news highlights sector momentum from IonQ's NVIDIA partnership, though RGTI's cash flow remains dependent on financing activities.
While analyst consensus is strongly bullish (85.7% buy ratings, $21.67 target), fundamental weaknesses pose significant risk. The stock offers speculative upside if commercialization accelerates, but high cash burn and negative profitability require careful monitoring of execution milestones against intense quantum computing competition.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Latest headlines on both assets
Humana is one of the largest private health insurers in the U.S. with a focus on administering Medicare Advantage plans. The firm has built a niche specializing in government-sponsored programs, with nearly all its medical membership stemming from individual and group Medicare Advantage, Medicaid, and the military's Tricare program. The firm is also a leader in stand-alone prescription drug plans for seniors enrolled in traditional fee-for-service Medicare. Humana offers employer-based plans primarily for small businesses along with specialty insurance offerings such as dental, vision, and life. Beyond medical insurance, the company provides other healthcare services, including primary-care services, at-home services, and pharmacy benefit management.
Read more on HUM →Rigetti Computing, Inc. is a pioneer in quantum computing, focusing on developing and deploying quantum-classical computing systems. The company designs and fabricates superconducting quantum processors and integrates them with a full-stack software and control platform. Rigetti offers access to its quantum computers through the cloud, aiming to solve complex computational problems that are intractable for classical computers, with applications in finance, chemistry, and machine learning.
Read more on RGTI →